Product Information
VALSARTAN 40 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0963 per EA under NDC 62332004490. Its NADAC has been published 534 times since Jul 13, 2016.
FDA first approved this application on Jan 5, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332004490
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA091367FDA Approved
1/5/2015
TE Code
AB
On Market Since
5/20/2016
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 40 MG TABLET has been published 534 times since Jul 13, 2016, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.3963 (Aug 14, 2019) |
| All-time low | $0.0871 (Apr 18, 2018) |
| 52-week high | $0.1219 |
| 52-week low | $0.0960 |
| Median price | $0.1517 |
| Average price | $0.1815 |
| Largest weekly change | +62.2% (Apr 22, 2020) |
| Weeks tracked | 534 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 40 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0963 per EA (NDC 62332004490), effective Sep 30, 2026.
How has the price of VALSARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 40 MG TABLET has declined 67.2%. It has been tracked across 534 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for VALSARTAN 40 MG TABLET?
Since Jul 13, 2016, the NADAC for VALSARTAN 40 MG TABLET has ranged from a low of $0.0871 (Apr 18, 2018) to a high of $0.3963 (Aug 14, 2019), with a median of $0.1517 per EA.
Are there cheaper alternatives to VALSARTAN 40 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN 40 MG TABLET?
VALSARTAN 40 MG TABLET (NDC 62332004490) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.